A. Antonini, E. Tolosa, Y. Mizuno, M. Yamamoto, and W. H. Poewe, A reassessment of risks and benefits of dopamine agonists in Parkinson's disease, Lancet Neurol, vol.8, issue.10, pp.929-937, 2009.

S. Bannier, J. L. Berdague, I. Rieu, I. De-chazeron, A. Marques et al., Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, vol.83, issue.10, pp.1019-1021, 2012.

S. M. Bauer, H. Schanda, H. Karakula, L. Olajossy-hilkesberger, P. Rudaleviciene et al., Culture and the prevalence of hallucinations in schizophrenia, Compr. Psychiatry, vol.52, issue.3, pp.319-325, 2011.

K. R. Chaudhuri, P. Martinez-martin, A. H. Schapira, F. Stocchi, K. Sethi et al., International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study, Mov. Disord, vol.21, issue.7, pp.916-923, 2006.

S. Chaudhury, Hallucinations: clinical aspects and management. Ind, Psychiatry J, vol.19, issue.1, pp.5-12, 2010.
DOI : 10.4103/0972-6748.77625
URL : https://doi.org/10.4103/0972-6748.77625

E. M. Cheng, S. Tonn, R. Swain-eng, S. A. Factor, W. J. Weiner et al., Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology, Neurology, vol.75, issue.22, pp.2021-2027, 2010.

, Text Revision American Psychiatric Association, Washington. Diagnostic and statistical manual of mental disorders, DSM-5(TM)), 2000.

N. J. Diederich, G. Fenelon, G. Stebbins, and C. G. Goetz, Hallucinations in Parkinson disease, Nat. Rev. Neurol, vol.5, issue.6, pp.331-342, 2009.

R. Drake, G. Haddock, N. Tarrier, R. Bentall, and S. Lewis, The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis, Schizophr. Res, vol.89, issue.1-3, pp.119-122, 2007.

G. Fenelon, F. Mahieux, R. Huon, and M. Ziegler, Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors, Brain, vol.123, pp.733-745, 2000.

G. Fenelon, T. Soulas, L. Cleret-de-langavant, I. Trinkler, and A. C. Bachoud-levi, Feeling of presence in Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, vol.82, issue.11, pp.1219-1224, 2011.

H. H. Fernandez, D. Aarsland, G. Fenelon, J. H. Friedman, L. Marsh et al., Scales to assess psychosis in Parkinson's disease: critique and recommendations, Mov. Disord, vol.23, issue.4, pp.484-500, 2008.

M. F. Folstein, S. E. Folstein, and P. R. Mchugh, Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res, vol.12, issue.3, pp.189-198, 1975.

E. B. Forsaa, J. P. Larsen, T. Wentzel-larsen, C. G. Goetz, G. T. Stebbins et al., A 12-year population-based study of psychosis in Parkinson disease, Arch. Neurol, vol.67, issue.8, pp.996-1001, 2010.

P. Franceschi, On the plausibility of psychotic hallucinations, Act. Nerv. Super, vol.53, issue.1-2, pp.35-43, 2011.

C. G. Goetz, W. Fan, and S. Leurgans, Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: positive impact on long-term worsening, Mov. Disord, vol.23, issue.11, pp.1541-1545, 2008.

C. G. Goetz, B. Ouyang, A. Negron, and G. T. Stebbins, Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study, Neurology, vol.75, issue.20, pp.1773-1779, 2010.

G. Goldman, C. Vaughan, and C. G. Goetz, An update expert opinion on management and research strategies in Parkinson's disease psychosis, Expert. Opin. Pharmacother, vol.12, issue.13, pp.2009-2024, 2011.

G. Haddock, J. Mccarron, N. Tarrier, and E. B. Faragher, Scales to measure dimensions of hallucinations and delusions: the Psychotic Symptom Rating Scales (PSYRATS), Psychol. Med, vol.29, issue.4, pp.879-889, 1999.

C. Hatton, G. Haddock, J. L. Taylor, J. Coldwell, R. Crossley et al., The reliability and validity of general psychotic rating scales with people with mild and moderate intellectual disabilities: an empirical investigation, J. Intellect. Disabil. Res, vol.49, pp.490-500, 2005.

M. A. Hely, J. G. Morris, W. G. Reid, and R. Trafficante, Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years, Mov. Disord, vol.20, issue.2, pp.190-199, 2005.

M. M. Hoehn and M. D. Yahr, Parkinsonism: onset, progression and mortality, Neurology, vol.17, issue.5, pp.427-442, 1967.
DOI : 10.1212/01.wnl.0000405146.06300.91
URL : http://n.neurology.org/content/77/9/874.full.pdf

A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J. Neurol. Neurosurg. Psychiatry, vol.55, issue.3, pp.181-184, 1992.

F. J. Jimenez-jimenez, M. Orti-pareja, T. Gasalla, A. Tallon-barranco, F. Cabreravaldivia et al., Cenesthetic hallucinations in a patient with Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, vol.63, issue.1, p.120, 1997.

S. R. Kay, A. Fiszbein, and L. A. Opler, The Positive and Negative Syndrome Scale (PANSS) for schizophrenia, Schizophr. Bull, vol.13, issue.2, pp.261-276, 1987.
DOI : 10.1093/schbul/13.2.261
URL : https://academic.oup.com/schizophreniabulletin/article-pdf/13/2/261/5413519/13-2-261.pdf

K. Koehler and H. Sauer, Jaspers' sense of presence in the light of Huber's basic symptoms and DSM-III, Compr. Psychiatry, vol.25, issue.2, pp.183-191, 1984.

S. Kumar, S. Soren, and S. Chaudhury, Hallucinations: etiology and clinical implications. Ind, Psychiatry J, vol.18, issue.2, pp.119-126, 2009.

F. Larøi and A. Aleman, Hallucinations: A Guide to Treatment and Management, 2010.

S. Leucht, M. Samara, S. Heres, M. X. Patel, S. W. Woods et al., Dose equivalents for second-generation antipsychotics: the minimum effective dose method, Schizophr. Bull, vol.40, issue.2, pp.314-326, 2014.

E. J. Pappert, C. G. Goetz, F. G. Niederman, R. Raman, and S. Leurgans, Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease, Mov. Disord, vol.14, issue.1, pp.117-121, 1999.
DOI : 10.1002/1531-8257(199901)14:1<117::aid-mds1019>3.3.co;2-s

J. R. Sanchez-ramos, R. Ortoll, and G. W. Paulson, Visual hallucinations associated with Parkinson disease, Arch. Neurol, vol.53, issue.12, pp.1265-1268, 1996.
DOI : 10.1001/archneur.1996.00550120077019

S. K. Schultz and N. C. Andreasen, Schizophrenia. Lancet, vol.353, issue.9162, pp.1425-1430, 1999.

I. E. Sommer, C. W. Slotema, Z. J. Daskalakis, E. M. Derks, J. D. Blom et al., The treatment of hallucinations in schizophrenia spectrum disorders, Schizophr. Bull, vol.38, issue.4, pp.704-714, 2012.

G. Stanghellini, A. I. Langer, A. Ambrosini, and A. J. Cangas, Quality of hallucinatory experiences: differences between a clinical and a non-clinical sample, World Psychiatry, vol.11, issue.2, pp.110-113, 2012.

D. L. Streiner and G. R. Norman, Health Measurement Scales: A Practical Guide to Their Development and Use, 2008.

, The Unified Parkinson's Disease Rating Scale (UPDRS), Mov. Disord, vol.18, issue.7, pp.738-750, 2003.

S. Thobois, Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature, Clin. Ther, vol.28, issue.1, pp.1-12, 2006.

B. Tousi and M. Frankel, Olfactory and visual hallucinations in Parkinson's disease. Parkinsonism Relat, Disord, vol.10, issue.4, pp.253-254, 2004.

K. Wada-isoe, K. Ohta, K. Imamura, M. Kitayama, T. Nomura et al., Assessment of hallucinations in Parkinson's disease using a novel scale, Acta Neurol. Scand, vol.117, issue.1, pp.35-40, 2008.

F. Waters, D. Collerton, D. H. Ffytche, R. Jardri, D. Pins et al., Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease, Schizophr. Bull, vol.40, pp.233-245, 2014.